Five Prime Therapeutics, Inc.: SC 13G/A filed Feb 15, 2022

Form type

SC 13G/A

Filing date

Feb 15, 2022

Accession number

0001172661-22-000969

Filer

Five Prime Therapeutics, Inc. (CIK 1175505)